{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T17:59:19Z","timestamp":1768672759906,"version":"3.49.0"},"reference-count":27,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pulmonary chronic graft-versus-host disease (PcGVHD) is a devastating complication of allogeneic hematopoietic stem cell transplant (HCT). The 2014 National Institutes of Health cGVHD consensus criteria (NIH criteria) only captures bronchiolitis obliterans syndrome (BOS). In this study, we adapted the 2019 International Society for Heart and Lung Transplantation (ISHLT) criteria of chronic lung allograft dysfunction (CLAD) to define novel phenotypes of PcGVHD and compared the performance of this criteria with the NIH criteria to identify patients with high-risk PcGVHD. We reviewed consecutive patients in a cGVHD natural history protocol (#NCT00092235) and adapted the 2019 CLAD criteria (the adapted criteria) to define PcGVHD as post-HCT forced expiratory volume at 1 second &amp;lt; 80% predicted value, with 4 phenotypes: obstructive, restrictive, mixed obstructive\/restrictive, and undefined. An independent adjudication committee evaluated subjects for diagnosis and phenotyping. We identified 166 (47.4%) patients who met the adapted criteria, including obstruction (n = 12, 3.4%), restriction (n = 67, 19.1%), mixed obstruction\/restriction (n = 47, 13.4%), and undefined (n = 40, 11.4%). In these patients, less than half (n = 78) met the NIH criteria for BOS (NIH+); the rest (n = 88) did not (NIH\u2212). The NIH\u2212 subjects showed increased risk of death compared with those without PcGVHD (hazard ratio = 1.88, 95% confidence interval = 1.20-2.95; P = .006) that was similar to NIH+ subjects (P = .678). Our study demonstrated the potential of the adapted criteria in identifying patients with high-risk PcGVHD that have been missed by the NIH criteria. The adapted criteria could become a valuable tool to better phenotype and study lung disease in cGVHD.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006885","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T21:00:56Z","timestamp":1651870856000},"page":"4196-4207","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":15,"title":["The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-8251","authenticated-orcid":false,"given":"Yifan","family":"Pang","sequence":"first","affiliation":[{"name":"1National Heart, Lung, and Blood Institute,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-1515","authenticated-orcid":false,"given":"Ananth V.","family":"Charya","sequence":"additional","affiliation":[{"name":"2Pulmonary Branch, National Heart, Lung, and Blood Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Keller","sequence":"additional","affiliation":[{"name":"3Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD;"},{"name":"4Department of Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arlene","family":"Sirajuddin","sequence":"additional","affiliation":[{"name":"5Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Fu","sequence":"additional","affiliation":[{"name":"6Office of Biostatistics Research, National Heart, Lung, and Blood Institute,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5706-1109","authenticated-orcid":false,"given":"Noa G.","family":"Holtzman","sequence":"additional","affiliation":[{"name":"7Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[{"name":"7Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[{"name":"4Department of Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, MD;"},{"name":"8Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"issue":"26","key":"2022071915272056100_B1","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med."},{"issue":"5","key":"2022071915272056100_B2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/17474086.2019.1605288","article-title":"A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease","volume":"12","author":"Csanadi","year":"2019","journal-title":"Expert Rev Hematol."},{"issue":"2","key":"2022071915272056100_B3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccm.2016.12.013","article-title":"Late-onset noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation","volume":"38","author":"Bergeron","year":"2017","journal-title":"Clin Chest Med."},{"issue":"3","key":"2022071915272056100_B4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"7","key":"2022071915272056100_B5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2010.11.018","article-title":"Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation","volume":"17","author":"Au","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"2022071915272056100_B6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/bmt.2013.17","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight: new perspectives?","volume":"48","author":"Ditschkowski","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"2022071915272056100_B7","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1182\/blood-2019-128226","article-title":"Prevalence of bronchiolitis obliterans syndrome (BOS) following allogeneic hematopoietic stem cell transplant (alloHSCT) in the USA, Europe and Japan","volume":"134","author":"Hofstetter","year":"2019","journal-title":"Blood."},{"issue":"1","key":"2022071915272056100_B8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12890-017-0466-7","article-title":"Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation","volume":"17","author":"Namkoong","year":"2017","journal-title":"BMC Pulm Med."},{"issue":"5","key":"2022071915272056100_B9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant."},{"key":"2022071915272056100_B10","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.bbmt.2009.11.002","article-title":"Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease","volume":"16","author":"Chien","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"2022071915272056100_B11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41409-018-0224-3","article-title":"Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients","volume":"54","author":"Kerep","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"2022071915272056100_B12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant."},{"issue":"15","key":"2022071915272056100_B13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2013-12-542720","article-title":"Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R","volume":"123","author":"Della Porta","year":"2014","journal-title":"Blood."},{"issue":"11","key":"2022071915272056100_B14","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.bbmt.2012.06.001","article-title":"Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial","volume":"18","author":"Finke","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"2022071915272056100_B15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2169\/internalmedicine.53.1124","article-title":"Pleuroparenchymal fibroelastosis as a series of airway complications associated with chronic graft-versus-host disease following allogeneic bone marrow transplantation","volume":"53","author":"Fujikura","year":"2014","journal-title":"Intern Med."},{"issue":"5","key":"2022071915272056100_B16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/his.13697","article-title":"Lung histopathology of non-infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation","volume":"73","author":"Meignin","year":"2018","journal-title":"Histopathology."},{"issue":"3","key":"2022071915272056100_B17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.10-1442","article-title":"Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation","volume":"139","author":"Barisione","year":"2011","journal-title":"Chest."},{"issue":"6","key":"2022071915272056100_B18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1183\/13993003.01121-2016","article-title":"Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation","volume":"48","author":"Greer","year":"2016","journal-title":"Eur Respir J."},{"issue":"10","key":"2022071915272056100_B19","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.rmed.2014.09.006","article-title":"Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation","volume":"108","author":"Schlemmer","year":"2014","journal-title":"Respir Med."},{"issue":"8","key":"2022071915272056100_B20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.bbmt.2014.04.008","article-title":"Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Cheng","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"2022071915272056100_B21","doi-asserted-by":"crossref","first-page":"1702617","DOI":"10.1183\/13993003.02617-2017","article-title":"Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation","volume":"51","author":"Bergeron","year":"2018","journal-title":"Eur Respir J."},{"issue":"5","key":"2022071915272056100_B22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1164\/ajrccm.165.5.2107059","article-title":"Internet-based home monitoring of pulmonary function after lung transplantation","volume":"165","author":"Morlion","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"issue":"8","key":"2022071915272056100_B23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.healun.2020.04.012","article-title":"Risk assessment of chronic lung allograft dysfunction phenotypes: validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system","volume":"39","author":"Levy","year":"2020","journal-title":"J Heart Lung Transplant."},{"issue":"12","key":"2022071915272056100_B24","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1111\/ajt.15550","article-title":"A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice","volume":"19","author":"Watanabe","year":"2019","journal-title":"Am J Transplant."},{"issue":"2","key":"2022071915272056100_B25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbmt.2009.09.016","article-title":"Influence of pretransplantation restrictive lung disease on allogeneic hematopoietic cell transplantation outcomes","volume":"16","author":"Ramirez-Sarmiento","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"2022071915272056100_B26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/rccm.200502-212OC","article-title":"Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation","volume":"172","author":"Parimon","year":"2005","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"2022071915272056100_B27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000444418","article-title":"Methods for measuring lung volumes: is there a better one?","volume":"91","author":"Tantucci","year":"2016","journal-title":"Respiration."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/14\/4196\/1907973\/advancesadv2021006885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/14\/4196\/1907973\/advancesadv2021006885.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T15:27:48Z","timestamp":1658244468000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/14\/4196\/485187\/The-ISHLT-chronic-lung-allograft-dysfunction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,7,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006885","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]}}}